- Supported exchanges /
- NSE /
- GUFICBIO.NSE
Gufic Biosciences Limited (GUFICBIO NSE) stock market data APIs
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.
Gufic Biosciences Limited Financial Data Overview
| 415.1 | |
| 407 | |
| - | |
| 418.95 | |
| 406.45 | |
| 277.5812-504.25 | |
| 41 625 M | |
| 48.9505 | |
| 100 M | |
| 8 145 M | |
| 0.0002 | |
| 0.796 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Gufic Biosciences Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 8 145 M
- EBITDA 1 465 M
- Earnings Per Share 8.48
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Gufic Biosciences Limited Earnings via APIs
- Latest Release 2024-11-07
- EPS/Forecast NaN
Get Gufic Biosciences Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
